Imugene Limited
Clinical trials sponsored by Imugene Limited, explained in plain language.
-
Experimental lung cancer vaccine trial halted early
Disease control TerminatedThis early-phase study tested a new immunotherapy called IMU-201 in 24 adults with advanced non-small cell lung cancer. The treatment was given alone or with other cancer drugs to see if it was safe and could shrink tumors. The study was terminated early, so results are limited.
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Experimental virus therapy VAXINIA tested in advanced cancer patients
Disease control TerminatedThis early-stage study tested a new treatment called VAXINIA (CF33-hNIS), a virus designed to attack cancer cells, in 66 adults with advanced solid tumors that had spread. The treatment was given alone or with the immunotherapy drug pembrolizumab, either as a shot into the tumor …
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Cancer-Fighting virus trial halted early: what we know
Disease control TerminatedThis early-phase study tested a new treatment called onCARlytics (a virus modified to attack cancer cells) combined with another drug, blinatumomab, in adults with advanced solid tumors that had not responded to prior therapies. The trial aimed to find a safe dose and check for s…
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC